In the ChemSynBio group (Chemical & Synthetic Biology for Biotherapies) we combine the power of chemical and synthetic biology to create protein-based precision therapeutics and biomedical tools. Our main goals are to treat brain tumors and other brain diseases, and to understand and improve drug transport across the blood-brain barrier.
ChemSynBio investiga y trabaja en transferencia de tecnología en la siguientes áreas:
- Development of bio- and nano- therapeutics, especially to treat brain tumors.
- Engineering and chemistry of antibodies, proteins, and peptides for biomedical applications.
- Study and engineering of transport systems to cross the blood-brain barrier.
- Development of conditionally-active proteins.
- Generation of new proteins through library selections and directed evolution.
Colaboradores externos
Sally Ward, PhD
University of SouthamptonManuel Valiente, PhD
Centro Nacional de Investigaciones Oncológicas (CNIO)David Baker, PhD
University of WashingtonBioengineering Department of IQS
Roberta Lucchi, Maria C Lucana, Montserrat Escobar, Pol Martín, Pedro Canhao, Adrià Puigdemont, Burcu Yaldiz
